Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NY: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about

< Previous 1 2
...
37 38 39 40 41 42 43 44 Next >
Elan to Present at Goldman Sachs 30th Annual Global Healthcare Conference
From Business Wire News Releases
Drug stocks advance; Elan, Antigenics soar
Drug stocks gain ground in early activity as shares of Elan Corp. soar on speculation that it could be taken over by Bristol-Myers Squibb. 
Tags Pharmaceuticals Biotechnology $DRG
From MarketWatch
Stocks Leap on Better Manufacturing Outlook Overseas
Better than expected manufacturing reports from Asia and Europe provided investors with a reason to buy stocks again. Meanwhile, oil prices rose above the $68 a barrel mark. The Dow soared more than... 
Tags Market News
From MarketMinute.com Market Updates
Elan Shares Soar On Buyout Speculation
Elan Shares Soar On Buyout Speculation 
Tags Health Care
From FOX Business
Monday's biggest gaining and declining stocks
Stocks expected to move significantly in Monday's trading include Bank of America, Elan, GM, Prudential, SunTrust, Tenet and Yahoo. 
Tags ELN AZN DE:BAS
From MarketWatch
Subset Data from Two Randomized Phase 3 Trials Show TYSABRI® Significantly Improves Health-Related Quality of Life for Crohn’s Disease Patients with Prior Exposure or Inadequate Response to Anti-TNF?
From Business Wire News Releases
Bristol-Myers reportedly in talks for Elan stake
Irish biotech firm Elan Corp. is reportedly in talks to sell a minority stake to Bristol-Myers Squibb Co. in a deal that could be a precursor to a full takeover. 
Tags M&A Company Announcements ELN
From MarketWatch
Elan May Sell Stake To Bristol Myers -- WSJ
Elan May Sell Stake To Bristol Myers -- WSJ 
Tags Health Care
From FOX Business
Renee P. Tannenbaum, Pharm.D. Joins Elan as Executive Vice President and Chief Commercial Officer
From Business Wire News Releases
Biogen Idec Joins with the Global MS Community to Mark World MS Day
From Business Wire News Releases
WallStSense.com Free Research Report for Shareholders of CUZ, DO, and ELN
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by WallStSense.com 
From Marketwired News Releases
Elan Announces Change in Board of Directors
From Business Wire News Releases
Acorda Therapeutics Announces FDA Acceptance of Fampridine-SR New Drug Application for Filing
From Business Wire News Releases
Cisco lower ahead of earnings: Put selling noted
Today’s tickers: CSCO, NYT, DRYS, INTC, VIX, MON, USB, CROX, IPG, ELN, & WFC CSCO Cisco Systems, Inc. – Shares are off slightly by less than 1% to $19.42 ahead of earnings expected for release from the... 
Tags VIX IPG CSCO
From Phil's Stock World
MRI Data Showing TYSABRI® Promoted Remyelination Presented at the 61st Annual Meeting of the American Academy of Neurology
From Business Wire News Releases
Elan and Transition Therapeutics Receive Key Patent for Alzheimer’s Disease Treatment with ELND005
From Business Wire News Releases
Elan Reports First Quarter 2009 Financial Results
From Business Wire News Releases
MaybachFinancial.com Posts Free Analyst Report on ELN, PKX, PH and FIS
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Maybach 
From Marketwired News Releases
Drug stocks mixed; Biogen slides on earnings report
Drug stocks mixed as the broader market traded largely flat in the wake of weak, yet better-than-expected earnings reports from Citigroup and General Electric. 
Tags Pharmaceuticals BIIB $DRG
From MarketWatch
Biogen Idec Receives Approval for TYSABRI® High Titer Production
From Business Wire News Releases
Biogen Idec Showcases Leading Multiple Sclerosis Franchise and Pipeline at the 61st Annual Meeting of the American Academy of Neurology
From Business Wire News Releases
Elan Announces Webcast of First Quarter 2009 Financial Results
From Business Wire News Releases
Drug stocks gain as broader market rallies
BOSTON (MarketWatch) -- Drug stocks gained in early action Thursday as the broader market cheerfully greeted better-than-expected earnings from financial sector heavyweight Wells Fargo. 
Tags ELN $BTK Biotechnology
From MarketWatch
WallStSense.com Free Research Report for Shareholders of ELN, BXP, MAT and NWL
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by WallStSense.com 
From Marketwired News Releases
Elan and Wyeth Plan to Amend Bapineuzumab Phase 3 Protocols
From Business Wire News Releases
Stocks to watch Thursday - Elan Corp, Marvell Technology and Life Partners Holdings
Chart courtesy of www.stockcharts.com ( click to enlarge ) The stock is sitting right on its 50 day moving average at $6.55. The overall outlook for the stock at this precise moment appears bullish.... 
Tags LPHI MRVL ELN
From AC Investor Blog
Elan Announces Filing of Annual Report for Year Ended December 31, 2008
From Business Wire News Releases
Schaeffer's Market Blog: Takeover Talk Triggers Call Trading on Elan Corporation (ELN)
From Business Wire News Releases
Drug stocks sag as Amgen climbs on upgrade
Drug stocks sag in early trading Friday while shares of Amgen Inc. rise on an upgrade from J.P. Morgan. 
Tags NVS GSK Company Announcements
From MarketWatch
Drugs stocks edge higher as market climbs on upbeat data
Drug stocks edge higher in early trading Wednesday as the broader market reacts positively to news that U.S. durable-goods orders for February came in significantly higher than expected. 
Tags NVO BIIB Stock Reports
From MarketWatch
< Previous 1 2
...
37 38 39 40 41 42 43 44 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.